Concepedia

Karl Eckert

KE

Statistics

Publications

17

Citations

904

H-Index

16

Active since

2001

Affiliations

Pharmacyclics (United States)(Current)

AbbVie (United States)

The University of Texas MD Anderson Cancer Center

Cornell University

Peter MacCallum Cancer Centre

Karl Eckert is an author at Pharmacyclics (United States) specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2001–2023

17

Publications

17

Engraftment of sorted/expanded human central nervous system stem cells from fetal brain

Stanley Tamaki, Karl Eckert, Dongping He et al. · Journal of Neuroscience Research · 2002 · 241 citations · Full text

, , +17

Construction and Molecular Analysis of Gene Transfer Systems Derived from Bovine Immunodeficiency Virus

Robert D. Berkowitz, Heini Ilves, WeiYu Lin et al. · Journal of Virology · 2001 · 83 citations

, , +17

The Role of PIM1 in the Ibrutinib-Resistant ABC Subtype of Diffuse Large B-Cell Lymphoma

Hsu-Ping Kuo, Sidney Hsieh, Karl J. Schweighofer et al. · Blood · 2015 · 64 citations

, , +8

Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Hsu-Ping Kuo, Scott A. Ezell, Karl J. Schweighofer et al. · Molecular Cancer Therapeutics · 2017 · 64 citations · Full text

, , +15

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.

Hsu-Ping Kuo, Scott A. Ezell, Sidney Hsieh et al. · PubMed · 2016 · 55 citations · Full text

, , +17

1–5 of 17